Stay updated on SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Sign up to get notified when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.

Latest updates to the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page
- Check4 days agoChange DetectedThe study page presents the completed trial of immediate-release viloxazine for adults with ADHD, with its design, participant criteria, interventions, and outcome measures. It also includes study history and links to the protocol and statistical analysis plan.SummaryDifference49%

- Check11 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The site revision identifier is updated to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the prior content. Access to the study details is blocked.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the page template or documentation. This change represents an internal update to the page versioning rather than a modification to the study information or user-facing content.SummaryDifference0.1%

Stay in the know with updates to SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.